SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689813-20-000014
Filing Date
2020-02-26
Accepted
2020-02-25 19:08:15
Documents
15
Period of Report
2020-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20200225.htm   iXBRL 8-K 59742
2 EX-99.1 a201910-kbhvnearningsp.htm EX-99.1 174038
  Complete submission text file 0001689813-20-000014.txt   396973

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20200225.xsd EX-101.SCH 2583
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20200225_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20200225_def.xml EX-101.DEF 1690
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20200225_lab.xml EX-101.LAB 23933
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20200225_pre.xml EX-101.PRE 12650
10 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20200225_htm.xml XML 10340
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 20652796
SIC: 2834 Pharmaceutical Preparations